Document is current

Any future updates will be listed below

Development of 1-(substituted benzofuran-2-yl)-3-(halogen-substituted phenyl)prop-2-en-1-ones as potent, reversible, and selective MAO-B inhibitors for Parkinson’s Disease

Crossref DOI link: https://doi.org/10.1038/s41598-026-53367-w

Published Online: 2026-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark